Advanced cancer care in Malaysia with personalised treatment for better outcomes
City Desk:
Bangladeshi patients seeking advanced cancer treatment abroad can now access personalised, targeted care at Ampang PuteriSpecialist Hospital (APSH) in Malaysia. Led by Consultant Clinical Oncologist Dr Azura Deniel, the hospital offers precision therapies and compassionate support focused on better treatment outcomes and patient well-being.
For many Bangladeshi families facing a cancer diagnosis, seeking treatment abroad is often a decision driven by the search for advanced care, experienced specialists and a more personalised approach. In Malaysia, APSH has become a trusted choice for patients seeking both medical expertise and compassionate support. At the heart of this commitment is Dr Azura Deniel, a Consultant Clinical Oncologist known for her expertise in precision oncology. With a focus on targeted treatment plans based on each patient’s unique cancer profile, Dr Azura is helping patients fight cancer with therapies designed to improve outcomes while reducing unnecessary side effects.
“We are no longer treating cancer as a single disease,” says Dr Azura. “Today, we customise therapy to each patient’s cancer profile, giving them a better chance at recovery with less harm to their overall health.”
At APSH, care extends beyond medical treatment. Dr Azura is known for taking the time to understand each patient’s lifestyle, concerns and support network, ensuring that treatment plans meet both medical needs and personal circumstances.
This personalised approach is supported by the hospital’s International Patient Centre (IPC), which helps ease the challenges of seeking care abroad.
“When we treat a patient, we are also supporting their family,”says Dr Azura. “We understand how much is at stake and that’s why we ensure each journey is as smooth and reassuring as possible.”
For Dr Azura, effective cancer care means combining medical precision with empathy and ongoing support. One of her most inspiring cases is Nadia, a 42-year-old mother of three from Johor who was diagnosed with Stage 3 HER2-positive breast cancer.
Under Dr Azura’s care, Nadia received a structured treatment plan that combined chemotherapy, HER2-targeted therapy and radiation therapy, all while receiving emotional and psychological support. Throughout her treatment journey, Dr Azura ensured that Nadia’s care aligned with her personal goals as a mother, a working professional and a woman determined to fight for her future.
Today, Nadia is in remission, back at work and actively advocating for early cancer screening in her community. Grateful for the care she received, she now shares her story to inspire others and raise awareness about the importance of personalised treatment.
“We are not just managing cells. We are caring for people, their relationships, their futures,” says Dr Azura.